Drug Profile
Research programme: ion channel antagonists - Neurocrine
Alternative Names: ion channel blockers - Neurocrine; ion channel inhibitors - NeurocrineLatest Information Update: 24 Feb 2011
Price :
$50
*
At a glance
- Originator Neurocrine Biosciences
- Class
- Mechanism of Action Ion channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported CNS disorders; Pain
Most Recent Events
- 24 Feb 2011 No development reported - Preclinical for CNS disorders in USA (unspecified route)
- 24 Feb 2011 No development reported - Preclinical for Pain in USA (unspecified route)